BC3 Technologies

The First and Only Patented FDA-Cleared Aerosol Hemostatic Spray

SEAL Hemostatic Wound Spray marks a significant advancement in emergency medical care, being the first and only patented FDA-cleared chitosan dry powder in aerosol form. This innovative product acts as a physical barrier, effectively sealing wounds to stop blood flow.

BC3 Technologies created SEAL after 15 years of development. But, BC3 Technologies is more than just a product manufacturer; we are a partner in the global effort to improve trauma care and save lives. Our commitment extends beyond the development of advanced hemostatic solutions; we are dedicated to raising awareness, educating the public, and supporting initiatives that address the critical issue of traumatic bleeding. Join us in our mission to transform wound care and make a meaningful difference in emergency response and trauma management.